# Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas

> **NCT01898078** · PHASE1 · COMPLETED · sponsor: **Millennium Pharmaceuticals, Inc.** · enrollment: 26 (actual)

## Conditions studied

- Advanced Solid Tumors
- Lymphoma

## Interventions

- **DRUG:** Alisertib

## Key facts

- **NCT ID:** NCT01898078
- **Lead sponsor:** Millennium Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-16
- **Primary completion:** 2014-03-05
- **Final completion:** 2017-01-24
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01898078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01898078, "Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01898078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*